1. Home
  2. HTCR vs PPBT Comparison

HTCR vs PPBT Comparison

Compare HTCR & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

HOLD

Current Price

$3.07

Market Cap

3.4M

Sector

Technology

ML Signal

HOLD

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

HOLD

Current Price

$1.76

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTCR
PPBT
Founded
2009
2010
Country
Japan
Israel
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4M
2.9M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
HTCR
PPBT
Price
$3.07
$1.76
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
94.5K
143.1K
Earning Date
05-14-2026
05-20-2026
Dividend Yield
87.84%
N/A
EPS Growth
414.29
N/A
EPS
N/A
N/A
Revenue
$30,407,229.00
N/A
Revenue This Year
$123.26
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
39.19
N/A
52 Week Low
$0.15
$0.41
52 Week High
$3.97
$5.18

Technical Indicators

Market Signals
Indicator
HTCR
PPBT
Relative Strength Index (RSI) 48.47 29.66
Support Level $2.80 $0.57
Resistance Level $3.86 $3.09
Average True Range (ATR) 0.39 0.25
MACD -0.04 -0.10
Stochastic Oscillator 11.34 22.75

Price Performance

Historical Comparison
HTCR
PPBT

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.

Share on Social Networks: